Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: AÂ Cohort Study

Among patients with gout, initiation of XOI was not associated with an increased or decreased cardiovascular risk compared with those with untreated hyperuricemia. Subgroup analyses adjusting for baseline uric acid levels also showed no association between XOI and cardiovascular risk.